Mode of action of currently used antiplatelet drugs.
D001241:Aspirin / Q000494:pharmacology* / Q000627:therapeutic use; D001792:Blood Platelets / Q000187:drug effects* / Q000201:enzymology; D001808:Blood Vessels / Q000187:drug effects; D002986:Clinical Trials as Topic; D016861:Cyclooxygenase Inhibitors; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects; D010980:Platelet Membrane Glycoproteins / Q000187:drug effects; D013442:Sulfinpyrazone / Q000494:pharmacology* / Q000627:therapeutic use; D013988:Ticlopidine / Q000494:pharmacology* / Q000627:therapeutic use
D016861:Cyclooxygenase Inhibitors; D010980:Platelet Membrane Glycoproteins; D013988:Ticlopidine; D001241:Aspirin; D013442:Sulfinpyrazone